SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640455-18-000113
Filing Date
2018-11-13
Accepted
2018-11-13 11:04:08
Documents
68
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q jnce0930201810-q.htm 10-Q 1186428
2 EXHIBIT 10.1 jnce09302018exhibit101.htm EX-10.1 14635
3 EXHIBIT 31.1 jnce09302018exhibit311.htm EX-31.1 10667
4 EXHIBIT 31.2 jnce09302018exhibit312.htm EX-31.2 10675
5 EXHIBIT 32.1 jnce09302018exhibit321.htm EX-32.1 11728
  Complete submission text file 0001640455-18-000113.txt   5784769

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT jnce-20180930.xml EX-101.INS 1197938
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnce-20180930.xsd EX-101.SCH 42152
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jnce-20180930_cal.xml EX-101.CAL 63386
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnce-20180930_def.xml EX-101.DEF 227151
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnce-20180930_lab.xml EX-101.LAB 551915
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnce-20180930_pre.xml EX-101.PRE 346043
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37998 | Film No.: 181176217
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1